Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). OBI Pharma's share price for the quarter that ended in Dec. 2025 was NT$54. OBI Pharma's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 131.58 Mil. Therefore, OBI Pharma's market cap for the quarter that ended in Dec. 2025 was NT$7,105.32 Mil.
OBI Pharma's quarterly market cap
declined
from Jun. 2025 (NT$8,599.05 Mil) to Sep. 2025 (NT$6,876.61 Mil) but then
increased
from Sep. 2025 (NT$6,876.61 Mil) to Dec. 2025 (NT$7,105.32 Mil).
OBI Pharma's annual market cap
declined
from Dec. 2023 (NT$15,909.77 Mil) to Dec. 2024 (NT$15,383.63 Mil) and
declined
from Dec. 2024 (NT$15,383.63 Mil) to Dec. 2025 (NT$7,105.32 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OBI Pharma's Enterprise Value for Today is NT$3,902.80 Mil.
OBI Pharma (ROCO:4174) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
OBI Pharma Market Cap Related Terms
OBI Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for OBI Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4174 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, OBI Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OBI Pharma Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OBI Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where OBI Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
OBI Pharma's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OBI Pharma (ROCO:4174) has a Market Cap of NT$3,736.87 Mil as of Jul. 15, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OBI Pharma and its competitors. According to the industry distribution chart, OBI Pharma ranks #709 out of 1423 companies in the Biotechnology industry, placing it in the top 49.8%.
Is OBI Pharma's Market Cap too high?
OBI Pharma's current Market Cap is NT$3,736.87 Mil. Based on the distribution chart, OBI Pharma ranks #709 out of 1423 companies in the Biotechnology industry, which is above the industry midpoint. Overall, OBI Pharma has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OBI Pharma's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OBI Pharma ranks #709 out of 1423 companies for Market Cap. This puts OBI Pharma in the upper half of its industry. The industry median Market Cap is 114.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.24, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OBI Pharma and its competitors. For the Biotechnology industry, the median Market Cap is 114.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OBI Pharma's current Market Cap is NT$3,736.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OBI Pharma stock overvalued right now?
Based on GuruFocus' analysis, OBI Pharma (ROCO:4174) is currently considered Possible Value Trap. The stock's GF Value™ is NT$138.61, compared to a current price of NT$28.40 — trading 79.5% below its estimated fair value. The current Market Cap is NT$3,736.87 Mil. OBI Pharma's overall GF Score™ is 43/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For OBI Pharma (ROCO:4174), the current Market Cap is NT$3,736.87 Mil as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OBI Pharma (ROCO:4174) Overvalued in 2026?
Based on GuruFocus' analysis, OBI Pharma stock appears to be undervalued.
The current stock price of NT$28.40 is trading 79.5% below its estimated GF Value™ of NT$138.61.
GuruFocus considers OBI Pharma to be Possible Value Trap.
Key valuation signals for ROCO:4174:
Market Cap: NT$3,736.87 Mil
GF Value™: NT$138.61 vs. price of NT$28.40 (79.5% below fair value)
No single metric tells the full story. See the ROCO:4174 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OBI Pharma Inc is engaged in the research and development of novel therapeutic agents and biologics for patients with unmet medical needs. The company has three reportable segments: the anti-cancer new drug segment, the botulinum toxin new drug segment, and the CDMO segment. Geographically, it generates the majority of its revenue from Taiwan.
43GF Score
Get the complete analysis for ROCO:4174
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4174 has been successfully added to your 
